Skin cancer in Asians part 1: Nonmelanoma skin cancer

Journal of Clinical and Aesthetic Dermatology

Volumn 2, Issue 8, 2009, Pages 39-42

  Kim, Grace K ^a   Del Rosso, James Q ^a,b  

^a Mohave Skin and Cancer Clinics   (United States)

^b VALLEY HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; BASAL CELL CARCINOMA; CULTURAL FACTOR; GENETICS; HUMAN; OCCUPATION; PATHOGENESIS; POPULATION; PRECANCER; RISK FACTOR; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 77954265971     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Armstrong BK, Kricker A. Skin caner. Dermatol Clin. 1995; 13: 583-594.
2. Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatol Surg. 1996; 22:217-226.
3. Ichihashi M, Naruse K, Harada S, et al. Trends in nonmelanoma skin cancer in Japan. Recent Results Cancer Res. 1995;139: 263-273.
4. Gloster H, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006; 55:741-760.
5. Koh D, Wang H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of Singapore Cancer Registry data 1968-97. British Association of Dermatologists. 2003; 148:1161-1166.
6. Stern RS. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol. 1999; 135:843-844.
7. Naruse K, Ueda M, Nagano T, et al. Prevalence of actinic keratosis in Japan. J Dermatol Sci. 1997; 15:183-187.
8. Ueda M, Matsunaga T, Bito T, et al. Higher cyclobutane pyrimidine dimer and photoproduct yields in epidermis of normal humans with increased sensitivity to UVB radiation. Photodermatol Photoimmunol Photomed. 1996; 12:22-26.
9. Takemiya M, Ohtsuka H, Yoshiharu M. The relationship between solar keratosis and squamous cell carcinomas among Japanese. J Dermatol. 1990; 17:342-346.
10. Araki N, Nagano T, Ueda M, et al. Incidence of skin cancers and precancerous lesions in Japanese: risk factors and prevention. J Epidemiol. 1999; 9:S14-S21.
11. Suzuki T, Ueda M, Naruse K, et al. Incidence of actinic keratosis of Japanese in Kasai City, Hyogo. J Dermatol Sci. 1997; 16:74-78.
12. Tada M, Miki Y. Malignant skin tumors among dermatology patients in university hospitals of Japan; a statistical survey, 1971-1979. J Dermatol. 1984; 11:313-321.
13. Nagano T, Ueda M, Suzuki T, et al. Skin cancer screening in Okinawa, Japan. J Dermatol Sci. 1999; 19:161-165.
14. Ishihara K. Nationwide survey of malignant skin tumors in Japan. Skin Cancer (Tokyo). 1994; 9:7-14.
15. Chia KS, Seow A, Lee HP, et al. Cancer Incidence in Singapore 1993-1997. Singapore Cancer Registry Report No. 5. Singapore: Singapore Cancer Registry; 2000.
16. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1998; 124:869-871.
17. Harland DL, Robinson W, Franklin W. Deletion of the p53 gene in the patient with aggressive burn scar carcinoma. J Trauma. 1997; 42:104-107.
18. Treves N, Pack G. The development of cancer in burn scars: an analysis and report of thirty-four cases. Surg Gynecol Obstet. 1930; 51:749-782.
19. Arons MS, Lynch JB, Lewis SR et al. Scar tissue carcinoma, part I: a clinical study with special reference to burn scar carcinoma. Ann Surg. 1965; 161:170-188.
20. Jellouli-Elloumi A, Kochbati L, Dhraief S, et al. Cancers arising from burn scars: 62 cases. Ann Dermatol Venereol. 2003; 130:413-416.
21. Ueda A, Suda K, Matsumoto T, et al. A clinicopathological and Immunohistochemical comparison of squamous cell carcinoma arising in scars versus non-scar SCC in Japanese patients. Am J Dermatopathol. 2006; 28:472-477.
22. Eroglu A, Berberoglu U, Berreroglu S. Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J Surg Oncol. 1996; 61:124-130.
23. Crawley W, Dellon A, Ryan J. Does host response determine the prognosis in scar carcinoma? Plast Reconstr Surg. 1978; 62:407-414.
24. Tohru N, Kunisada M, Yu X, et al. Involvement of Interleukin-10 promoter polymorphisms in nonmelanoma skin cancers: A case study in non-Caucasian skin cancer patients. Photochem Photobiol. 2008; 84:63-65.
25. Nishigor C. Cellular aspects of photocarcinogenesis. Photochem Photobiol Sci. 2006; 208-214.
26. Salazar-Onfray F. Interleukin 10: A cytokine used by tumors to escape immunosurveillance. Med Oncol. 1999; 16:86-94.
27. Hollstein M, Sidranscky D, Vogelstein B, et al. P53 mutations in human cancers. Science. 1991; 253:49-53.
28. Cho S, Hahma J, Hong Y. Analysis of p53 and BAX mutations, loss of heterozygosity, p53 and BCL2 expression and apoptosis in basal cell carcinoma in Korean patients. Br J Dermatol. 2001; 144:841-848.
29. Kubo Y, Urano Y, Yoshimoto K, et al. P53 gene mutations in human skin cancers and precancerous lesions: comparision with immunohistchemical analysis. J Invest Dermatol. 1994; 102:440-444.
30. Kaldor J, Shugg D, Young B, et al. Nonmelanoma skin cancer: ten years of cancer-registry-based surveillance. Int J Cancer. 1993; 53:886-889.
31. Gallagher RP, Ma B, McLean DI, et al. Trends in basal cell carcinoma, squamous cell carcinoma and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol. 1990;23:413-421.
32. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other non-melanoma skin cancers in Finland through 1956-1995. Arch Dermatol. 1999; 135:781-786.
33. Green A, Battistutta D, Hart V, et al. Skin cancer in the subtropical Australian population: incidence and lack of association with occupation. Am J Epidemiol. 1996; 144:1034-1040.
34. Stern R. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol. 1999;135:843-844.
35. Stephens T, Oresajo C. Ethnic sensitive skin: a review. Cosmetics Toiletries. 1994:109:75-80.